baber/WOPTO huggingface dataset:
Patent NO-882901-D0 (NO)
IPC: F02B47/04
Filed: 1988-06-29
Abstract: PCT No. PCT/SE86/00515 Sec. 371 Date May 9, 1989 Sec. 102(e) Date May 9, 1989 PCT Filed Nov. 12, 1986 PCT Pub. No. WO88/03550 PCT Pub. Date May 19, 1988.A method and a composition for providing an improved combustion containing hydrocarbon compounds in order to reduce the content of injurious substances in the exhaust gases/discharges, at which a liquid composition containing 10-80% by volume of a peroxide or peroxo compound is added to the air of combustion or the fuel-air mixture respectively.
Patent NO-884857-D0 (NO)
Inventor: HILGE BERNARD
IPC: F27D15/02
Filed: 1988-11-01
Abstract: A convection cooling vessel for materials exhibiting surfaces in arrangements with interspaces which can be flowed through, in particular of block charges made of light metal semifinished products, has a fan which delivers into an exhaust duct and on the suction side of which a forked pipe is arranged; on each leg of the forked pipe, there is a shut-off and control valve. Provided symmetrically in relation to the material are inflow ducts which are assigned to the legs of the forked pipe. Each inflow duct has a further shut-off and control valve. The shut-off and control valves in the forked pipe and in the inflow ducts can be adjusted in such a manner that, because of the suction effect of the fan, the material can be flowed through in the main flow or in the part flow and the flow direction of the cooling medium can be reversed. <IMAGE>
Patent NO-885239-D0 (NO)
Inventor: COLOMBIER CHRISTIAN
IPC: C08G77/54
Filed: 1988-11-24
Abstract: New polymers containing a plurality of -NR-Si- units and oxygen. 
<??>The invention also relates to a process for the preparation of these polysiloxazanes by reacting a halosilane with a hydrazine and water. 
<??>The polysiloxazanes obtained can be shaped and pyrolysed to ceramics.
Patent NO-891012-D0 (NO)
Inventor: NEWTON CLIVE ROBERT
IPC: C12Q1/68
Filed: 1989-03-09
Abstract: A method for detecting the presence or absence of one or more variant nucleotide sequences. The method comprises (i) contacting a nucleic acid sample with a diagnostic primer which is substantially complementary to a diagnostic portion of a target base sequence, whereby extension of the diagnostic portion on a target template under appropriate conditions is only achieved where a terminal nucleotide of the diagnostic primer is complementary to either a suspected variant nucleotide or a corresponding normal nucleotide of the target base sequence, and (ii) detecting the presence or absence of an extension product. Kits for performing diagnostic tests are also disclosed.
Patent NO-892002-D0 (NO)
Inventor: DANILEWICZ JOHN C
IPC: C07C233/57
Filed: 1989-05-18
Abstract: S Enantiomeric diuretic agent of the formula: <CHEM> wherein each R and R<4> is H or one of R and R<4> is H and the other is a biolabile ester group, a process for their preparation and intermediates therefor.
Patent NO-895226-D0 (NO)
Inventor: OKITA MAKOTO
IPC: C07C49/83
Filed: 1989-12-22
Abstract: A naphthalene derivative having the formula is new and useful for medicine. <CHEM> [wherein R<1> represents a hydrogen atom, a lower alkyl group or an acyl group; R<2> independently represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a halogen atom, a cycloalkyl group, a cycloalkylalkyl group, a hydroxyl group, an aryl group which may be substituted, an arylalkyl group whose aryl group may be substituted, a heteroaryl group, or a heteroarylalkyl group; R<3> and R<4> are the same or different and represent a hydrogen atom, a lower alkyl group, a lower alkenyl group, an aryl group which may be substituent, an arylalkyl group whose aryl group may be substituted, an arylalkenyl group whose aryl group may be substituted, a cycloalkyl group, an alkoxyalkyl group, a heteroaryl group, a heteroarylalkyl group, a carboxyl group, a carboxyalkyl group, an aminoalkyl group, or a cyano group; R<5> represents a group of the formula, -OR<7>, (wherein R<7> represents a hydrogen atom or a lower alkyl group), or a group of the formula, <CHEM> (wherein R<8> and R<9> are the same or different and represent a hydrogen atom or alower alkyl group or R<8> and R<9> can form, along with the nitrogen atom bonded with R<8> and R<9>, a ring which may contain an oxygen atom); R<6> independently represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a hydroxyl group, an amino group, an arylalkyl group, or an aryl group; and m is 0 or an integer of from 1 to 2, and n is 0 or an integer of from 1 to 4.]
Patent NO-904431-D0 (NO)
Inventor: NUTT RUTH F
IPC: C07K5/107
Filed: 1990-10-12
Abstract: A fibrinogen receptor antagonist of the formula <CHEM> wherein XX represents a synthetic alpha-amino acid containing a linear side chain and ZZ represents a sequence of 1, 2, 3 or 4 amino acids.
Patent NO-905611-D0 (NO)
Inventor: MOHN FRANK
IPC: B01F3/08
Filed: 1990-12-28
Abstract: A liquid is supplied to a vessel (10) to form a pool (21) from which it discharges through a venturi. A supply pipe or pipes (12,30) convey other liquids and/or gases from separate sources or from above the liquid pool into the venturi for mixing with the liquid. The supply pipes can extend through the pool and be perforated (22) to tend to maintain the level of the pool. Associated with the venturi are pressure sensors (40,41) for measuring flow and a densiometer (52) permitting mass flow rate measurement of gas and liquid phases. The apparatus can be incorporated in a cartridge (60) for reception in a receptacle (61) at a subsea installation. <IMAGE>
Patent NO-910811-D0 (NO)
Inventor: ANDERSON STEPHEN
IPC: C12N9/72
Filed: 1991-02-28
Abstract: Tissue plasminogen activator (t-PA) zymogens and variants are prepared, including a fibrinolytically active variant of t-PA that has an amino acid alteration at a site within the protease domain of t-PA as compared with the corresponding wild-type t-PA, which alteration renders the variant zymogenic in the presence of plasmin-degraded fibrinogen, and/or fibrin (or plasma clot) specific, as compared to the corresponding wild-type t-PA. DNA sequences can be prepared that encode the zymogens and variants, as well as expression vectors incorporating the DNA sequences, and host cells transformed with the expression vectors. The zymogens and variants may be used in a pharmaceutical preparation to treat a vascular disease or condition or to prevent fibrin deposition or adhesion formation or reformation in mammals.
Patent NO-923387-D0 (NO)
Inventor: GONZE MICHEL HENRI ANDRE
IPC: A23G3/42
Filed: 1992-08-28
Abstract: A lozenge contains a binder such as gelatine and a sweetener which is partly or totally erythritol or maltitol. A process for making the lozenge comprises kneading the erythritol or maltitol at an elevated temperature, e.g. 35 to 60 DEG C, while slowly adding an aqueous solution of the binder, kneading the erythritol or maltitol and binder into a smooth paste, forming the paste into suitable shapes and heating the shapes at an elevated temperature, e.g. 40 to 45 DEG C, to harden them.
Patent NO-930594-D0 (NO)
Inventor: ENGLERT HEINRICH
IPC: C07D213/89
Filed: 1993-02-19
Abstract: Arylcarbonylaminoalkyl-dihydro-oxo-pyridines of Formula I <CHEM> are disclosed wherein aryl is an aromatic or heteroaromatic system, n is zero through 5; R and R(1), are hydrogen, or loweralkyl; W is hydrogen, (hetero)-(aryl)-loweralkyl; Z is hydrogen, CH2OR(2), CHO, (CO)OR(2), (CO)NR(2)2. Processes for the preparation of compound I are also disclosed. Compounds I are suitable for the treatment of disorders of the cardiovascular system, for example of hypertension, of cardiac insufficiency or of disturbances of blood flow in the coronary systems such as, for example, angina. Disturbances of cerebral and peripheral blood flow are likewise influenced beneficially. Furthermore, compounds I are able to influence smooth-muscle organs such as uterus, bronchi, intestines and biliary system, the urinary tract (ureter, bladder and urethra) in the sense of spasmolysis. They are therefore also suitable for the treatment of diseases associated with spasms of these organs, for example for the treatment of premature labor in pregnancy, of ureteral or biliary colic, of obstructive airway diseases such as asthma, of disturbances of intestinal motility such as, for example, of irritable colon or of bladder incontinence. Additionally, compounds of formula I can serve as anti-convulsants in the treatment of epilepsy and as hair growth inducers in the treatment of baldness.
Patent NO-940854-D0 (NO)
Inventor: BACHELARD ROLAND
IPC: C01F7/00
Filed: 1994-03-10
Abstract: The process consists in reacting aluminium nitride with  alpha -alumina and with an alumina with a high specific surface or a precursor which generates an alumina with a high specific surface. More precisely, the process consists in mixing the aluminium nitride, the  alpha -alumina and the alumina with a high specific surface or the precursor of such an alumina, in drying the said mixture, in heating the said mixture at a temperature sufficient to obtain a gamma -aluminium oxynitride powder and then in grinding the powder thus obtained. The agglomerated  gamma -aluminium oxynitride powder is characterised in that the porosity of the agglomerate is greater than 75%. The ground  gamma -aluminium oxynitride powder is characterised in that 100% of the particles have a size of less than 10  mu m and in that it has a transmittance of at least 8% measured at 2500 cm<-1> on a KBr disc with a thickness of 0.9 mm containing 3.33% of  gamma -aluminium oxynitride.
Patent NO-954410-D0 (NO)
Inventor: PATEL RAJNIKANT
IPC: C07C277/08
Filed: 1995-11-03
Abstract: PCT No. PCT/GB94/00966 Sec. 371 Date Feb. 22, 1995 Sec. 102(e) Date Feb. 22, 1995 PCT Filed May 5, 1994 PCT Pub. No. WO94/26701 PCT Pub. Date Nov. 24, 1994   <IMAGE>  (II)   <IMAGE>  (III)  A process is disclosed for the preparation of NG-monoalkyl-L-arginine and related compounds and salts thereof, for example NG-monomethyl-L-arginine by reacting N-alkylaminoiminomethane sulphonic acid of formula (II) with an amino acid of formula (III).
Patent NO-961377-D0 (NO)
Inventor: BERIA ITALO
IPC: A61K31/415
Filed: 1996-04-03
Abstract: PCT No. PCT/EP95/02814 Sec. 371 Date Mar. 18, 1996 Sec. 102(e) Date Mar. 18, 1996 PCT Filed Jul. 18, 1995 PCT Pub. No. WO96/05196 PCT Pub. Date Feb. 22, 1996The present invention relates to compounds of formula (I)    <IMAGE>  (I)    <IMAGE>   The compounds of the invention are useful as antitumor or antiviral agents.
Patent NO-964448-D0 (NO)
Inventor: EKSTROM CHRISTIAN ROSS
IPC: E21B7/20
Filed: 1996-10-18
Abstract: PCT No. PCT/SE95/00434 Sec. 371 Date Mar. 31, 1997 Sec. 102(e) Date Mar. 31, 1997 PCT Filed Apr. 21, 1995 PCT Pub. No. WO95/29321 PCT Pub. Date Nov. 2, 1995A casing tube formed from plastic and a casing shoe formed from metal are provided for drilling in layers of earth or rock. The casing shoe is locked to the casing tube by threads, grooves or flanges provided on a reduced diameter portion of the casing shoe. A tube-formed extension is provided in the casing shoe for protecting the casing tube from damage during a drilling operation.
Patent NO-992534-D0 (NO)
Inventor: PEET NORTON P
IPC: C07D215/38
Filed: 1999-05-26
Abstract: A process of converting a hydroxy heteroaromatic compound to an arylamine, comprising the steps of : 1) treating a salt of a hydroxy heteroaromatic compound with an alkylating agent; and 2) treating the reaction mixture with a Smiles solvent system and raising the temperature of the reaction mixture; and a compound made according to the above process.
Patent NO-995218-D0 (NO)
Inventor: NILSSON ERIC
IPC: G09F1/04
Filed: 1999-10-26
Abstract: A folder comprising a sheet (1) which is pleated in a concertina-like fashion (10, 11, 12) and which, in a pleated state, is folded around fold lines (14, 15) that extend perpendicularly to the pleat line (10, 11, 12) in the pleated sheet, wherein the sheet (1) is surrounded by a protective cover (2) when in a fully folded-up state. The two sheet fold-lines (14, 15) extending perpendicular to the pleat lines (10, 11, 12) face in mutually the same direction, so as to enable the two end-panels of the pleated sheet (1) to be folded in overlapping relationship with the center panel. The cover (2) is a paperboard cover against which one pleated panel (40) of the sheet is fastened in a centered position on one side of the cover (2), wherein the cover also includes fold lines (24, 25) which coincide generally with the fold lines (14, 15) on the sheet (1). The cover is provided on the inner (23) of the two mutually overlapping outer panels (21, 23) a tongue (26) which receives therebeneath the free end of the outer (21) of the two mutually overlapping outer panels (21, 23), which panels also overlap the center panel (22) when the folder is in a fully folded-up state.
Patent GB-0000922-D0 (GB)
Title: Priority enhanced messaging and method therefor
IPC: H04L29/06
Filed: 2000-01-14
Abstract: A serial bus (106) communication protocol communicates data packets. When priority messages are identified, transmission of a data packet (302) being transmitted, if any, is interrupted. The priority message (402) is transmitted. Thereafter, transmission of an interrupted data packet is completed.
Patent GB-0007626-D0 (GB)
Title: Road lamp
IPC: E01F9/615
Filed: 2000-03-29
Abstract: The light assembly 10 designed to be fixed to a structure, such as a traffic cone 18 includes a lamp 12 which may be a standard incandescent bulb, a light emitting diode or any other suitable lamp and a fan 14; this may be located below the lamp 12 <WC 1>and is fitted on a spindle (20). Within body 22 of the assembly 10 standard electrical components are provided for transducing rotation of the fan 14 into electrical energy. The assembly 10 may include a rechargeable battery which is recharged by the electrical power generated by the fan 14. At the base of the unit <WC 1>10 there is provided a fixing 16 for fixing the unit 10 to the top of a traffic cone 18. The fan 14 is caused to rotate by natural wind or by air turbulence caused by moving traffic. This fan rotation causes generation of electrical energy within the transducer mechanism which is used to power the lamp 12 and to recharge the rechargeable battery.
Patent GB-0016618-D0 (GB)
Title: Method of particle formation
IPC: A61K31/135
Filed: 2000-07-07
Abstract: The invention provides a method for forming particles of a target substance, comprising (a) co-introducing into a particle formation vessel, under controlled temperature and pressure, a supercritical or near-critical anti-solvent fluid; a first target substance in a first vehicle; and a second target substance in a second vehicle; and (b) using the anti-solvent to disperse the target substances in their respective vehicles and to extract the vehicles, substantially simultaneously and substantially immediately on introduction of the fluids into the particle formation vessel. The second vehicle is immiscible with the first, and contact between the first and second vehicles occurs a sufficiently short period of time before their dispersion by the anti-solvent, and with sufficient physical mixing, as to allow only insignificant, if any, phase separation to occur between the two vehicles between their contact with one another and their dispersion.
Patent GB-0031300-D0 (GB)
Title: Electrostatic application of powder material to solid dosage forms in an elect ric field
IPC: A61K9/20
Filed: 2000-12-21
Abstract: A method of electrostatically applying a powder material to a solid dosage form comprises the following steps: applying a bias voltage to generate an electric field between a source ( 1 ) of the powder material and the solid dosage form ( 5 ); applying an electrostatically charged powder material to the solid dosage form ( 5 ), the powder material being driven onto the solid dosage form ( 5 ) by the interaction of the electric field with the charged powder material, an the presence of the charged powder material on the solid dosage form serving to build up an electric charge on the solid dosage form ( 5 ) and thereby reduce the electric field generated by the bias voltage between the source ( 1 ) of powder material and the solid dosage form ( 5 ), and continuing the application of the electrostatically charged powder material to the solid dosage form ( 5 ) until the electric field between the source ( 1 ) of powder material and the solid dosage form is so small that the driving of the powder material by the electric field onto the solid dosage form ( 5 ) is substantially terminated.
Patent GB-0115849-D0 (GB)
Title: Video/image communication with watermarking
IPC: H04N7/24
Filed: 2001-06-28
Abstract: A video communication unit ( 405, 450 ) comprising a video input ( 415 ) for receiving a video signal transmission having a number of video or image frames, wherein each video or image frame includes a number of bit planes, the video input being operably coupled to a processor, the video communication unit characterised by said processor ( 410, 460 ) replicating at least one bit plane in at least two video or image frames to provide a tamper detection means of the video or image signal transmission. This enables fraudulent tampering of images and video to be detected, and the location of such tampering to be revealed to users of the material.
Patent GB-0414675-D0 (GB)
Title: Arrangement for triggering a vehicle safety device
IPC: B60R21/0134
Filed: 2004-06-30
Abstract: An arrangement for triggering a motor vehicle safety device. The arrangement incorporates a proximity sensor (1) which is configured to provide a proximity signal related to the distance to an object and/or the relative speed between the object and the sensor (1). The arrangement also includes an accelerometer (2) and a first processing unit (3) which is configured to perform an arming algorithm on signals received from the proximity sensor (1) and the accelerometer (2). A second processing unit (6) is provided to perform a crash algorithm on signals received from the proximity sensor (1) and the accelerometer (2). The arrangement incorporates a logic gate (4) to generate a triggering signal (5) in response to simultaneous output of signals from the first processing unit (3) and the second processing unit (6).
Patent GB-0513956-D0 (GB)
Title: Housing of circuit boards
IPC: H05K1/02
Filed: 2005-07-07
Abstract: A fiber optic module has a PCB with high frequency tracks. The PCB is housed within a housing having top and bottom parts, each having a series of metallized ridges. The PBC has through holes filled with solder. Thus, there is a series of electrical interconnections through the PBC, and the total length of any enclosed periphery is much shorter than the full periphery of the board so that high frequencies are attenuated.
Patent GB-0517611-D0 (GB)
Title: Golf club head of ductile or gray iron
IPC: A63B59/00
Filed: 2004-02-27
Abstract: A golf club head made of a ferrous metal and having a density in the range from about 5 to about 6.8 g/cm<3 >and from about 7.0 to about 7.4 g/cm<3>, and such heads made of a cast ferrous metal having a density in the range from about 5 to about 7.4 g/cm<3>. The entire golf club head may be made of such ferrous metal. Or, the ferrous metal is preferably a ductile iron or gray iron. The ferrous metal may be present as an insert in the ball hitting face of the club head, and the body of the club head may be a material different from the ferrous material. Or, the body of the club head may be made of the ferrous metal and the ball hitting face of the club head may be a different material.
Patent GB-0609099-D0 (GB)
Title: Methods and system for replicating and securing process control data
IPC: G06F11/30
Filed: 2004-10-18
Abstract: Methods and systems are provided to replicate and secure process control system data. Devices coupled to a process control network produce data that is collected by a host on the network. This data may be provided to users of computers that are not on the process control network, without increasing the network's vulnerability to network attacks. To achieve this security, an isolation system including a firewall and an application workstation are placed between the host and the non-network computers. The host pushes the data through the firewall to the application workstation, which includes the same application program interface found on the host. Thus, non-network computers can not identify that the data provided to them is coming from the application workstation instead of the process control network. The firewall is configured to prevent most or all outside communications with the network. Thus, the network is protected from attacks while providing its data to non-network computers.
Patent GB-0610849-D0 (GB)
Title: Method to support multiple mobility protocols in a flexible reconfigurable mobile terminal
IPC: H04W80/00
Filed: 2006-06-01
Abstract: A method to enhance the design of flexible network protocol stack to concurrently support multiple modular mobility protocols is based on the derived framework enabling the design of such a flexible reconfigurable terminal. It can further control at run time the mobility protocols and thus transparently operate more than one protocol simultaneously, for example, both macro and micro mobility protocols. A dynamic protocol database 180 stores the location of the various protocol modules in the memory 150. A single reconfiguration element is maintained in a Generic Mobility Components 130 and is controlled by an Event Identifier in the Generic Mobility Component Manager 110. The Event Identifier 114 is enhanced to process all incoming events and reconfigure the elements to the related part of the Protocol Database according to the relevant protocol the event is associated with. The resulting flexible architecture employs an enhanced protocol component design and may be implemented in numerous manners and platforms. A mobile terminal 100 with this architecture may move around and transparently connect to different access networks. It is further enabled to operate concurrently more than one protocol to fulfil various application scenarios and their requirements. This enables mobile terminals to become more intelligent and operate flexibly in a heterogeneous multi-access network environment with multiple protocol support.
Patent GB-0613470-D0 (GB)
Title: Protein
Filed: 2006-07-06
Abstract: This invention relates to a protein, termed INSP 189, herein identified as a secreted protein, in particular, as a member of the four helical bundle cytokine family, and more particularly as an IL-22 like protein and to the use of this protein and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease.
Patent GB-0621707-D0 (GB)
Title: Formulations for delivery via pressurised metered dose inhalers
Filed: 2006-10-31
Abstract: A formulation suitable for delivery from a pressurised metered dose inhaler comprises a hydrofluoroalkane liquid, which is pharmaceutically acceptable, for instance HFA 134a or HFA 227, a drug to be delivered to the lung which is insoluble in the hydrofluoroalkane, the drug being in particulate form in the composition, further containing a suspension stabiliser which is a non-toxic essential oil miscible with the hydrofluoroalkane liquid at room temperature. The essential oil is preferably one having some amphiphilic property, such as a ketone or aldehyde compound. Insulin may be formulated for inhalation.
Patent GB-8323555-D0 (GB)
Title: Marking apparatus
IPC: H02B13/00
Filed: 1983-09-02
Abstract: A marking apparatus for providing individual marker sleeves for cables is arranged to receive tubing 16 and transport it lengthwise of itself past a marking head of the apparatus, the marking head being responsive to command signals supplied to it from a character generation unit 12 to mark the tubing with required indicia or characters. Downstream of the marking head, a cutting mechanism is provided for severing or semi-severing the tubing according to the required individual marker sleeves 18.